Published in Eur J Med Res on December 07, 2009
FKBP51 and FKBP52 in signaling and disease. Trends Endocrinol Metab (2011) 1.34
FKBP51-a selective modulator of glucocorticoid and androgen sensitivity. Curr Opin Pharmacol (2011) 0.96
Molecular mechanisms of repeated social defeat-induced glucocorticoid resistance: Role of microRNA. Brain Behav Immun (2014) 0.79
The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases. Microbiol Mol Biol Rev (2016) 0.76
Glucocorticoid therapy and ocular hypertension. Eur J Pharmacol (2016) 0.75
Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK. Front Immunol (2017) 0.75
Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci U S A (2007) 4.21
Glucocorticoid resistance in inflammatory diseases. Lancet (2009) 3.57
FKBP family proteins: immunophilins with versatile biological functions. Neurosignals (2008) 1.94
Glucocorticoid-induced increase in lymphocytic FKBP51 messenger ribonucleic acid expression: a potential marker for glucocorticoid sensitivity, potency, and bioavailability. J Clin Endocrinol Metab (2003) 1.92
Differential control of glucocorticoid receptor hormone-binding function by tetratricopeptide repeat (TPR) proteins and the immunosuppressive ligand FK506. Biochemistry (2005) 1.67
Essential role for Co-chaperone Fkbp52 but not Fkbp51 in androgen receptor-mediated signaling and physiology. J Biol Chem (2006) 1.66
Low-dose theophylline enhances the anti-inflammatory effects of steroids during exacerbations of COPD. Thorax (2009) 1.65
Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates. Gen Comp Endocrinol (2001) 1.57
Long-acting beta2-adrenoceptor agonists synergistically enhance glucocorticoid-dependent transcription in human airway epithelial and smooth muscle cells. Mol Pharmacol (2007) 1.31
Attenuation of the activity of the cAMP-specific phosphodiesterase PDE4A5 by interaction with the immunophilin XAP2. J Biol Chem (2003) 1.27
Receptor accessory folding helper enzymes: the functional role of peptidyl prolyl cis/trans isomerases. FEBS Lett (2001) 1.20
FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness. Invest Ophthalmol Vis Sci (2008) 1.11
Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP. Carcinogenesis (2001) 1.02
Pharmacology of airway inflammation in asthma and COPD. Pulm Pharmacol Ther (2003) 0.92
Targeted ablation reveals a novel role of FKBP52 in gene-specific regulation of glucocorticoid receptor transcriptional activity. J Steroid Biochem Mol Biol (2008) 0.92
Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun (2008) 0.91
Theophylline for COPD. Thorax (2006) 0.90
Global expression profiling of theophylline response genes in macrophages: evidence of airway anti-inflammatory regulation. Respir Res (2005) 0.88
Cytoplasm-nuclear trafficking of CREB and CREB phosphorylation at Ser133 during therapy of chronic obstructive pulmonary disease. J Physiol Pharmacol (2007) 0.88
Sputum induction in corticosteroid-dependant asthmatics: risks and airway cellular profile. Asian Pac J Allergy Immunol (2005) 0.83
Expression of CREB-binding protein and peroxisome proliferator-activated receptor gamma during formoterol or formoterol and corticosteroid therapy of chronic obstructive pulmonary disease. J Physiol Pharmacol (2008) 0.82
Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment. J Physiol Pharmacol (2008) 0.81
Theophylline inhibits NF-kappa B activation and I kappa B alpha degradation in human pulmonary epithelial cells. Naunyn Schmiedebergs Arch Pharmacol (2001) 0.80
Acetaminophen metabolism and cytotoxicity in PC12 cells transfected with cytochrome P4502E1. J Mol Med (Berl) (1997) 1.47
Indacaterol add-on therapy improves lung function, exercise capacity and life quality of COPD patients. Adv Exp Med Biol (2013) 0.98
Prognostic molecular markers in non-small cell lung cancer. Lung Cancer (2001) 0.95
Severe respiratory distress caused by central airway obstruction treated with self-expandable metallic stents. J Physiol Pharmacol (2008) 0.89
Cytoplasm-nuclear trafficking of CREB and CREB phosphorylation at Ser133 during therapy of chronic obstructive pulmonary disease. J Physiol Pharmacol (2007) 0.88
Diagnostic and prognostic value of the new tumour marker CYFRA 21-1 in patients with squamous cell lung cancer. Eur Respir J (1995) 0.88
Angiogenic axis angiopoietin-1 and angiopoietin-2/Tie-2 in non-small cell lung cancer: a bronchoalveolar lavage and serum study. Adv Exp Med Biol (2013) 0.88
Novel cytokines: IL-27, IL-29, IL-31 and IL-33. Can they be useful in clinical practice at the time diagnosis of lung cancer? Exp Oncol (2012) 0.86
Molecular basis of chronic inflammation in lung diseases: new therapeutic approach. J Physiol Pharmacol (2007) 0.85
Increased levels of interleukin-12 and interleukin-18 in bronchoalveolar lavage fluid of patients with pulmonary sarcoidosis. J Physiol Pharmacol (2008) 0.85
CYFRA 21-1 as a tumour marker for bronchogenic carcinoma. Eur Respir J (1995) 0.85
Acetaldehyde cytotoxicity in cultured rat astrocytes. Brain Res (1999) 0.85
Imaging with extended focal depth by means of lenses with radial and angular modulation. Opt Express (2007) 0.84
Effect of angiotensin II and vasopressin on acquisition and extinction of conditioned avoidance in rats. Psychopharmacology (Berl) (1983) 0.84
Clinical Significance of HMGB-1 and TGF-β Level in Serum and BALF of Advanced Non-Small Cell Lung Cancer. Adv Exp Med Biol (2015) 0.83
Imaging with extended focal depth by means of the refractive light sword optical element. Opt Express (2008) 0.83
Upregulation of Th1 cytokine profile in bronchoalveolar lavage fluid of patients with hypersensitivity pneumonitis. J Physiol Pharmacol (2008) 0.83
[Lungs in the Marfan syndrome--case report with the light and the scanning microscope data (author's transl)]. Przegl Lek (1978) 0.82
Circulating Thrombospondin-2 and FGF-2 in Patients with Advanced Non-small Cell Lung Cancer: Correlation with Survival. Adv Exp Med Biol (2015) 0.82
Comparison of induced sputum and bronchoalveolar lavage fluid cell profile during the treatment of pulmonary sarcoidosis. J Physiol Pharmacol (2007) 0.82
Evaluation of CYFRA 21-1 as a new marker for non-small cell lung cancer. Eur J Cancer Prev (1994) 0.82
Expression of CREB-binding protein and peroxisome proliferator-activated receptor gamma during formoterol or formoterol and corticosteroid therapy of chronic obstructive pulmonary disease. J Physiol Pharmacol (2008) 0.82
Propofol protects rat astroglial cells against tert-butyl hydroperoxide-induced cytotoxicity; the effect on histone and cAMP-response-element-binding protein (CREB) signalling. J Physiol Pharmacol (2009) 0.82
Intrastriatal kainic acid: acute effects on electrophysiological and biochemical measures of nigrostriatal dopaminergic activity. J Pharmacol Exp Ther (1981) 0.82
Usefulness of a multiple biomarker assay in bronchoalveolar lavage (BAL) and serum for the diagnosis of small cell lung cancer. Neoplasma (1993) 0.81
Diffractive elements of variable optical power and high diffraction efficiency. Appl Opt (1993) 0.81
Serum levels of IGF-I and IGF-II in patients with lung cancer during chemotherapy. Exp Oncol (2004) 0.81
Chronic obstructive pulmonary disease: an update on nuclear signaling related to inflammation and anti-inflammatory treatment. J Physiol Pharmacol (2008) 0.81
Increased levels of Treg cells in bronchoalveolar lavage fluid and induced sputum of patients with active pulmonary sarcoidosis. Eur J Med Res (2009) 0.80
Involvement of central beta2-adrenergic, NMDA and thromboxane A2 receptors in the pressor effect of anandamide in rats. Naunyn Schmiedebergs Arch Pharmacol (2010) 0.80
Serum levels of sFas and sFasL during chemotherapy of lung cancer. Exp Oncol (2007) 0.80
Losartan influences behavioural effects of angiotensin II in rats. Pharmacol Res (1997) 0.80
Activity and tissue localization of cathepsin G in non small cell lung cancer. Rocz Akad Med Bialymst (1997) 0.80
[Behavior of adenosine triphosphoric acid (ATP) in the blood of rheumatic patients]. Reumatologia (1965) 0.80
Cerebrospinal fluid IL-6, TNF-α and MCP-1 in children with acute lymphoblastic leukaemia during chemotherapy. Neuropediatrics (2011) 0.79
Value of CEA and SCC-Ag in bronchoalveolar lavage (BAL) and serum of patients with lung carcinoma. Neoplasma (1992) 0.79
Design of potent and selective linear antagonists of vasopressor (V1-receptor) responses to vasopressin. J Med Chem (1990) 0.79
Strehl ratios characterizing optical elements designed for presbyopia compensation. Opt Express (2011) 0.79
Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer. Rocz Akad Med Bialymst (2004) 0.79
Anti-inflammatory effects of atorvastatin treatment in chronic obstructive pulmonary disease. A controlled pilot study. J Physiol Pharmacol (2015) 0.79
Inhaled corticosteroids increase siglec-5/14 expression in sputum cells of COPD patients. Adv Exp Med Biol (2015) 0.78
Imaging properties of the light sword optical element used as a contact lens in a presbyopic eye model. Opt Express (2011) 0.78
Preoperative CYFRA 21-1 level as a prognostic indicator in resected primary squamous cell lung cancer. Br J Cancer (1996) 0.78
Significance of the cell adhesion molecules and sialic acid in neurodegeneration. Adv Med Sci (2012) 0.78
Immunohistochemical analysis of tissue localization of cytokeratin 19 in lung cancer. Rocz Akad Med Bialymst (1997) 0.78
The impact of immune responses on lung cancer and the development of new treatment modalities. Lung Cancer (2001) 0.78
Carboxy terminus of vasopressin required for activity but not binding. Nature (1984) 0.78
Detection of human papillomavirus in non-small cell lung carcinoma by polymerase chain reaction. Folia Histochem Cytobiol (2001) 0.78
Lipopolysaccharide changes sialylation pattern in the mouse central nervous system. J Physiol Pharmacol (2012) 0.77
Therapy increases poly-ADP-ribose and p53-Ser392-P levels in recurrent squamous cell lung cancer. Neoplasma (2003) 0.77
Biological and diagnostic role of cathepsin D. Rocz Akad Med Bialymst (1997) 0.77
Studies on angiogenesis intensity in lung cancer in aspect of its correlation with histological type of tumor and clinical stage. Rocz Akad Med Bialymst (1997) 0.77
Nuclear HSP90 and HSP70 in COPD patients treated with formoterol or formoterol and corticosteroids. Eur J Med Res (2009) 0.77
Detection of p16 abnormalities in early-stage non-small cell lung cancer. Folia Histochem Cytobiol (2001) 0.77
The role of calcium in paracetamol (acetaminophen) cytotoxicity in PC12 cells transfected with CYP4502E1. Inflammopharmacology (1998) 0.77
[The role of human papilloma viruses (HPV) in the pathogenesis of lung neoplasms]. Pneumonol Alergol Pol (2000) 0.76
6-OHDA lesions to amygdala and hippocampus attenuate memory-enhancing effect of the 3-7 fragment of angiotensin II. Gen Pharmacol (1998) 0.76
Dopaminergic projection to the septum mediates facilitatory effect of angiotensins on recognition memory in rats. Pharmacol Res (1997) 0.76
Morphological and molecular aspects of cancerogenesis in the lung. Folia Histochem Cytobiol (2001) 0.76
Altered histone deacetylase activity and iNOS expression in cells isolated from induced sputum of COPD patients treated with tiotropium. Adv Exp Med Biol (2013) 0.76
Interleukin-33 as a New Marker of Pulmonary Sarcoidosis. Adv Exp Med Biol (2015) 0.76
Proteolytic enzymes in proliferation and neoplastic metastases formation. Rocz Akad Med Bialymst (1997) 0.76
C-terminal deletions in agonistic and antagonistic analogues of vasopressin that improve their specificities for antidiuretic (V2) and vasopressor (V1) receptors. J Med Chem (1987) 0.75
Morphology of lung mast cells in rats treated with bleomycin. Exp Toxicol Pathol (1996) 0.75
Dermatomyositis masquerading as pulmonary embolism. Eur J Med Res (2009) 0.75
Histone acetylation and arachidonic acid cytotoxicity in HepG2 cells overexpressing CYP2E1. Naunyn Schmiedebergs Arch Pharmacol (2013) 0.75
Churg-Strauss syndrome: a case report. Eur J Med Res (2010) 0.75
Lung mass in a 28-year-old male: a case report of a rare tumor. Eur J Med Res (2010) 0.75
Losartan influences behavioural effects of angiotensin II(3-7) in rats. Pharmacol Res (1997) 0.75
Strong association between P53 protein accumulation, serum antibodies and gene mutation in non-small cell lung cancer. Folia Histochem Cytobiol (2001) 0.75
Tiotropium increases cytosolic muscarinic M3 receptors and acetylated H3 histone proteins in induced sputum cells of COPD patients. Eur J Med Res (2010) 0.75
Serum endostatin levels in patients with lung carcinoma. Rocz Akad Med Bialymst (2005) 0.75
[Coagulation and fibrinolysis in interstitial lung diseases]. Pneumonol Alergol Pol (1999) 0.75
p53 gene mutation and protein expression in operable non-small cell lung cancer in Poland. Eur J Cancer Prev (2000) 0.75
[Tuberculosis of ear and cutis]. Pneumonol Alergol Pol (2001) 0.75
[Tuberculosis of the bone]. Pneumonol Alergol Pol (2001) 0.75
[Usefulness of flow cytometric evaluation of DNA ploidy analysis in lung cancer]. Pneumonol Alergol Pol (2000) 0.75
[Clinical significance of measuring levels of interleukin 2(IL-2) and it's soluble interleukin 2 receptor in serum of patients with lung cancer]. Pneumonol Alergol Pol (1999) 0.75
Serum levels of osteoprotegerin (OPG) and pro gastrin releasing peptide (ProGRP) during chemotherapy of lung cancer. Rocz Akad Med Bialymst (2004) 0.75